✦ LIBER ✦

A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine

✍ Scribed by Arvydas Ambrozaitis; Nicola Groth; Roberto Bugarini; Vittoria Sparacio; Audino Podda; Maria Lattanzi

Book ID: 116961871
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 428 KB
Volume: 27
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2009.07.083

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a trivalent

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

✍ Scott A Halperin; Bruce Smith; Taoufik Mabrouk; Marc Germain; Pierre Trépanier; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Safety, tolerability and immunogenicity

Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial

✍ N. Groth; E. Montomoli; C. Gentile; I. Manini; R. Bugarini; A. Podda 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Harvesting and concentration of human in

Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines

✍ Bernd Kalbfuss; Yvonne Genzel; Michael Wolff; Anke Zimmermann; Robert Morenweise 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 2 views

## Abstract A process scheme for the harvesting and concentration of cell culture‐derived human influenza A virus is presented. The scheme comprises two static filtration steps, chemical inactivation by β‐propiolactone and cross‐flow ultrafiltration. Human influenza A virus A/PR/8/34 (H1N1) was pro